Solicitation of Nominations for Appointment to the Advisory Committee on Immunization Practices (ACIP)., 14855-14856 [2018-07048]
Download as PDF
<![CDATA[
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 67 / Friday, April 6, 2018 / Notices
the Director, Centers for Disease Control
and Prevention, are authorized under
Sections 301 and 308 of the Public
Health Service Act to conduct directly
or by grants or contracts, research,
experiments, and demonstrations
relating to occupational safety and
health and to mine health. The Board of
Scientific Counselors provides guidance
to the Director, National Institute for
Occupational Safety and Health on
research and prevention programs.
Specifically, the Board provides
guidance on the Institute’s research
activities related to developing and
evaluating hypotheses, systematically
documenting findings and
disseminating results. The Board
evaluates the degree to which the
activities of the National Institute for
Occupational Safety and Health: (1)
Conform to appropriate scientific
standards, (2) address current, relevant
needs, and (3) produce intended results.
Matters To Be Considered: The agenda
for the meeting addresses occupational
safety and health issues related to: (1)
Use of contribution analysis to evaluate
research impact; (2) breach in the
protective barrier system of the glove
and gown interface; (3) occupational
safety and health workforce training;
and (4) safe-skilled-ready workforce
update—Research for Young and
Temporary Workers.
Agenda items are subject to change as
priorities dictate. An agenda is also
posted on the NIOSH website (https://
www.cdc.gov/niosh/bsc/). Members of
the public who wish to address the
NIOSH BSC are requested to contact the
Executive Secretary for scheduling
purposes (see contact information
below). Alternatively, written comments
to the BSC may be submitted via an online form at the following website:
https://www.cdc.gov/niosh/bsc/
contact.html. Agenda items are subject
to change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–07049 Filed 4–5–18; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
19:21 Apr 05, 2018
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public; however, visitors must be
processed in accordance with
established federal policies and
procedures. Attendance is limited only
by room seating available, (add number
of seats that will be available in the
room). The public is also welcome to
listen to the meeting via teleconference;
100 teleconference lines are available.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt of written public
comment is May 3, 2018. All requests
must contain the name, address, and
organizational affiliation of the speaker,
as well as the topic being addressed.
Written comments should not exceed
one single-spaced typed page in length
and delivered in 3 minutes or less.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Please note that the
public comment period may end before
the time indicated, following the last
call for comments. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. Registration is required to
attend in person or on the phone.
Interested parties may register at
www.cdc.gov/hicpac.
DATES: The meeting will be held on May
17, 2018, 9:00 a.m. to 5:00 p.m., EDT,
and May 18, 2018, 9:00 a.m. to 12:00
p.m., EDT.
ADDRESSES: Centers for Disease Control
and Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE, Atlanta, Georgia 30329
and teleconference at 866–692–3582,
passcode: 66783078.
FOR FURTHER INFORMATION CONTACT: Erin
Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
SUMMARY:
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
14855
CDC, 1600 Clifton Road NE, Mailstop
A–07, Atlanta, Georgia 30329,
Telephone (404) 639–4045. Email
hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Health and Human Services, regarding
(1) the practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
The Healthcare Personnel Guideline
Workgroup; the National Healthcare
Safety Network (NHSN) Workgroup; the
Neonatal Intensive Care Unit (NICU)
Guideline Workgroup; and the Products
and Practices Workgroup. Agenda items
are subject to change as priorities
dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–07050 Filed 4–5–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory
Committee on Immunization Practices
(ACIP).
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
SUMMARY:
E:\FR\FM\06APN1.SGM
06APN1
daltland on DSKBBV9HB2PROD with NOTICES
14856
Federal Register / Vol. 83, No. 67 / Friday, April 6, 2018 / Notices
ACIP. The ACIP consists of 15 experts
in fields associated with immunization
practices and public health, have
expertise in the use of vaccines and
other immunobiologic agents in clinical
practice or preventive medicine, have
expertise with clinical or laboratory
vaccine research, or have expertise in
assessment of vaccine efficacy and
safety. The committee shall include a
person or persons knowledgeable about
consumer perspectives and/or social
and community aspects of
immunization programs. Nominations
are being sought for individuals who
have expertise and qualifications
necessary to contribute to the
accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of
vaccines and related agents for effective
control of vaccine-preventable diseases
in the civilian population of the United
States. Members may be invited to serve
for four-year terms. Selection of
members is based on candidates’
qualifications to contribute to the
accomplishment of ACIP objectives
https://www.cdc.gov/vaccines/acip/
committee/charter.html.
DATES: Nominations for membership on
the ACIP must be received no later than
August 1, 2018. Packages received after
this time will not be considered for the
current membership cycle.
ADDRESSES: All nominations should be
emailed to ACIP Secretariat, ACIP@
cdc.gov.
FOR FURTHER INFORMATION CONTACT: Ms.
Stephanie Thomas, Committee
Management Specialist, CDC, NCIRD,
1600 Clifton Road NE, MS–A27,
Atlanta, GA 30329–4027, telephone
(404) 639–8367, email ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status; female and minority nominees
are strongly encouraged to apply.
Nominees must be U.S. citizens, and
cannot be full-time employees of the
U.S. Government. Current participation
on federal workgroups or prior
experience serving on a federal advisory
committee does not disqualify a
candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
VerDate Sep<11>2014
19:21 Apr 05, 2018
Jkt 244001
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ACIP membership each year, and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2019, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year.
Nominees must be U.S. citizens, and
cannot be full-time employees of the
U.S. Government. Candidates should
submit the following items:
D A cover letter that includes a
statement of interest and the
qualifications and expertise of the
nominee for serving on ACIP.
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–07048 Filed 4–5–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0932]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Information
Collection for Evaluation of Education,
Communication, and Training Activities
for Mobile Populations to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on October
30, 2017 to obtain comments from the
public and affected agencies. CDC
received four comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Information Collection for Evaluation
of Education, Communication, and
Training Activities for Mobile
Populations (OMB Control Number
0920–0932, Expiration 07/31/2018)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
E:\FR\FM\06APN1.SGM
06APN1
]]>Agencies
[Federal Register Volume 83, Number 67 (Friday, April 6, 2018)]
[Notices]
[Pages 14855-14856]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07048]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Committee on Immunization Practices (ACIP).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the
[[Page 14856]]
ACIP. The ACIP consists of 15 experts in fields associated with
immunization practices and public health, have expertise in the use of
vaccines and other immunobiologic agents in clinical practice or
preventive medicine, have expertise with clinical or laboratory vaccine
research, or have expertise in assessment of vaccine efficacy and
safety. The committee shall include a person or persons knowledgeable
about consumer perspectives and/or social and community aspects of
immunization programs. Nominations are being sought for individuals who
have expertise and qualifications necessary to contribute to the
accomplishments of the committee's objectives. Nominees will be
selected based on expertise in the fields of vaccines and related
agents for effective control of vaccine-preventable diseases in the
civilian population of the United States. Members may be invited to
serve for four-year terms. Selection of members is based on candidates'
qualifications to contribute to the accomplishment of ACIP objectives
https://www.cdc.gov/vaccines/acip/committee/charter.html.
DATES: Nominations for membership on the ACIP must be received no later
than August 1, 2018. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to ACIP Secretariat,
[email protected].
FOR FURTHER INFORMATION CONTACT: Ms. Stephanie Thomas, Committee
Management Specialist, CDC, NCIRD, 1600 Clifton Road NE, MS-A27,
Atlanta, GA 30329-4027, telephone (404) 639-8367, email [email protected].
SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human
Services policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status;
female and minority nominees are strongly encouraged to apply. Nominees
must be U.S. citizens, and cannot be full-time employees of the U.S.
Government. Current participation on federal workgroups or prior
experience serving on a federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning and annually
during their terms. CDC reviews potential candidates for ACIP
membership each year, and provides a slate of nominees for
consideration to the Secretary of HHS for final selection. HHS notifies
selected candidates of their appointment near the start of the term in
July 2019, or as soon as the HHS selection process is completed. Note
that the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year.
Nominees must be U.S. citizens, and cannot be full-time employees
of the U.S. Government. Candidates should submit the following items:
[ssquf] A cover letter that includes a statement of interest and
the qualifications and expertise of the nominee for serving on ACIP.
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-07048 Filed 4-5-18; 8:45 am]
BILLING CODE 4163-18-P
